IgG4-Associated Cholangitis--A Mimic of PSC

Area of Science:

• Immunology
• Gastroenterology
• Pathology

Background:

• IgG4-associated cholangitis (IAC) is a biliary manifestation of IgG4-related disease (IgG4-RD), often mimicking other conditions like primary sclerosing cholangitis (PSC) and cholangiocarcinoma.
• Current diagnostic standards (HISORt criteria) rely on histopathology, imaging, serology, other organ involvement, and treatment response.
• Accurate differentiation is crucial for appropriate immunosuppressive treatment and management.

Purpose of the Study:

• To present novel findings enhancing the diagnosis and understanding of IgG4-related disease (IgG4-RD).
• To identify specific biomarkers for distinguishing IgG4-RD from other biliary diseases.
• To explore potential risk factors for IgG4-RD development.

Main Methods:

• Next-generation sequencing (NGS) to identify dominant IgG4+ B-cell clones.
• Analysis of serum IgG4 and IgG1 levels (sIgG4/sIgG1 ratio).
• Quantification of blood IgG4 mRNA levels.
• Review of clinical data and exposure history.

Main Results:

• Dominant IgG4+ B-cell clones identified by NGS are highly specific for IgG4-RD, aiding differentiation from PSC and malignancies.
• A serum IgG4/IgG1 ratio greater than 0.24 provides additional diagnostic value in differentiating IAC from PSC.
• Blood IgG4 mRNA levels demonstrate high accuracy comparable to NGS for distinguishing IgG4-RD.
• Occupational exposure to solvents, paints, and industrial gases may be a risk factor for IgG4-RD.

Conclusions:

• NGS-identified IgG4+ B-cell clones and blood IgG4 mRNA are accurate biomarkers for IgG4-RD diagnosis.
• The sIgG4/sIgG1 ratio enhances diagnostic capability in differentiating IAC from PSC.
• Environmental or occupational exposures may contribute to IgG4-RD pathogenesis.
• These advancements facilitate earlier and more accurate diagnosis and treatment of IgG4-RD.